Browse Category

NASDAQ:SLS News 18 October 2025 - 8 December 2025

SELLAS Life Sciences (SLS) Stock on December 8, 2025: ASH 2025 Data, Cash Runway and Analyst Targets Over $6

Market data in this article are as of December 8, 2025, 09:13 UTC. Where SLS Stock Stands Today SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) is trading at around $1.74 per share in early trading on December 8, 2025, barely

8 December 2025

Sellas Life Sciences (SLS) Stock Skyrockets: BlackRock’s 5% Bet and Breakthrough Cancer Data Ignite Rally

Sellas Life Sciences (NASDAQ: SLS) stock has surged roughly 100% year-to-date, closing around $2.14 on Oct. 17, 2025 ts2.tech ts2.tech (versus a 52-week low of $0.77). In after-hours trading on Oct. 17 it spiked another +38%, briefly touching a new

20 October 2025

Biotechnology · Cancer Research · Financial Analysis · Investment News · NASDAQ:SLS · Stock Market

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Stock Price and Performance As of mid-October 2025, Sellas Life Sciences (NASDAQ:SLS) trades around $2.10–2.20. This is near the top of its 52-week range ($0.77 low) and about twice its price at the start of 2025 stockanalysis.com marketbeat.com. Trading volume

18 October 2025

Biotechnology · Investment Analysis · Leukemia Research · NASDAQ:SLS · Pharma News · Stock Market

BlackRock’s Big Bet Sends SELLAS Life Sciences (SLS) Stock Soaring – What’s Next for This Biotech?

Key Facts – October 18, 2025 Stock Performance: SLS on a Tear in 2025 SELLAS Life Sciences’ stock has been on a remarkable run this year. Shares have effectively doubled in 2025, and the momentum accelerated in mid-October. On Friday

18 October 2025

Biotech · Financial Analysis · Investing · Market News · NASDAQ:SLS · Stocks

Go toTop